000			01935 a2200577 4500
005			20250517204956.0
264		0	_c20190920
008			201909s 0 0 eng d
022			_a1600-0641
024	7		_a10.1016/j.jhep.2018.02.033 _2doi
040			_aNLM _beng _cNLM
100	1		_aYang, Hung-Chih
245	0	0	_aQuantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection. _h[electronic resource]
260			_bJournal of hepatology _c08 2018
300			_a286-292 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aBiomarkers _xblood
650	0	4	_aDNA, Viral _xblood
650	0	4	_aFemale
650	0	4	_aHepatitis B _xcomplications
650	0	4	_aHepatitis B Antibodies _xblood
650	0	4	_aHepatitis B Surface Antigens _xblood
650	0	4	_aHepatitis B virus _xphysiology
650	0	4	_aHumans
650	0	4	_aLymphoma, Non-Hodgkin _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPredictive Value of Tests
650	0	4	_aRisk Assessment _xmethods
650	0	4	_aRituximab _xtherapeutic use
650	0	4	_aTaiwan
650	0	4	_aVirus Activation _ximmunology
700	1		_aTsou, Hsiao-Hui
700	1		_aPei, Sung-Nan
700	1		_aChang, Cheng-Shyong
700	1		_aChen, Jia-Hong
700	1		_aYao, Ming
700	1		_aLin, Shyh-Jer
700	1		_aLin, Johnson
700	1		_aYuan, Quan
700	1		_aXia, Ningshao
700	1		_aLiu, Tsang-Wu
700	1		_aChen, Pei-Jer
700	1		_aCheng, Ann-Lii
700	1		_aHsu, Chiun
773	0		_tJournal of hepatology _gvol. 69 _gno. 2 _gp. 286-292
856	4	0	_uhttps://doi.org/10.1016/j.jhep.2018.02.033 _zAvailable from publisher's website
999			_c28191255 _d28191255